T 2436/18 (Anti-sclerostin antibody therapy/AMGEN) of 10.09.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T243618.20210910
- Date of decision
- 10 September 2021
- Case number
- T 2436/18
- Petition for review of
- -
- Application number
- 12180292.0
- IPC class
- C07K 16/18A61K 39/395A61P 19/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Method for inhibiting bone resorption
- Applicant name
- Amgen, Inc
- Opponent name
- James Poole Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Agreement to text withdrawn by patent proprietor - appeal dismissed
- Catchword
- -
- Cited cases
- T 0454/15
- Citing cases
- T 1306/22
Order
For these reasons it is decided that:
The appeal is dismissed.